Tata 1mg raises $40M under Tata Digital's direction, becoming a unicorn

Tata 1mg diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.

E-pharmacy platform Tata 1MG crossed the coveted billion-dollar valuation mark after raising about $40 million (Rs 319.4 crore) in a round led by Tata Digital. Other investors participating in the round include MPOF Mauritius Ltd, HBM Healthcare, and KWE Beteiligung.

Tata Digital invested close to $32 million (Rs 254.6 crore), while KWE Beteiligung put in close to $2.35 million (Rs 18.7 crore), according to filings with the Registrar of Companies.

In May 2019, a leading consulting firm predicted the Indian e-pharma market to grow >7 times between 2019 and 2023 expected to reach US$ 2.7 billion (Rs.199 billion) by 2023, from US$ 360 million (Rs. 26.5 billion), at a staggering CAGR of 65.5%.

The company has issued 30,992 shares at a price of Rs 1,03,047 per share.

The company did not disclose the valuation of the deal but the infusion is set to have valued the health tech startup at $1.25 billion, according to several media reports, thus achieving unicorn status.

The fundraising will help Tata 1mg fend off rivals, including Reliance-backed Netmeds and Tiger Global-backed Pharmeasy.

The company did not comment on the development.

Tata 1mg allows users to buy medicines and health products online and also facilitates teleconsultation and lab testing.

Tata Digital, a subsidiary of conglomerate Tata Sons, acquired 1mg in mid-2021 to strengthen its presence in the consumer and health tech spaces. It acquired the fitness platform, Curefit, in June last year. At the time, 1mg operated three diagnostics labs, and had a supply chain covering over 20,000 pin codes across India.

“Trust is the most important currency in healthcare, and there is no other brand in India that is more synonymous with trust than the Tata Group,” Gaurav Agarwal, Co-founder and Chief Technology Officer (CTO) of 1mg, said earlier on the acquisition.

It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs.

It’s diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.

Tags : #tata1mg #funding #fundingalert #ReliancebackedNetmeds #medicircle #smitakumar

About the Author


Shweta Yadav

I strive to provide you with the most current and up-to-date healthcare news and articles in all main areas. Within the Medicircle umbrella, a wide range of themes and categories concerning health.

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
Are online spaces safe for women?December 08, 2023
Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023